Share Price and Basic Stock Data
Last Updated: December 13, 2025, 8:49 am
| PEG Ratio | 4.28 |
|---|
Analyst Insight & Comprehensive Analysis
AI Stock Ranker – Real-Time Fundamental Strength Score
Business Overview and Revenue Trends
Rane (Madras) Ltd operates in the auto ancillary sector, primarily focusing on the manufacturing of steering and suspension systems. For the fiscal year ending March 2025, the company reported a notable revenue of ₹3,406 Cr, reflecting a significant increase from ₹2,354 Cr in the previous year. This upward trend is indicative of a recovery trajectory post the pandemic, as the company has been ramping up its production capabilities and expanding its market reach. Quarterly sales figures also tell a compelling story; the most recent data shows a spike in sales, peaking at ₹853 Cr in March 2025, compared to ₹622 Cr in March 2023. This growth trajectory suggests a strong demand for their products, possibly driven by the resurgence in the automotive sector as consumers look to upgrade their vehicles. However, fluctuations in quarterly sales, such as the decline to ₹521 Cr in December 2023, raise questions about seasonal demand and market volatility, which could pose challenges ahead.
Profitability and Efficiency Metrics
When assessing Rane’s profitability, the company recorded an operating profit margin (OPM) of 8% for the fiscal year ending March 2025, consistent with the industry average but still below the peak of 9% observed in March 2023. This stability in margins suggests that while Rane is managing its operational costs effectively, it may face pressures from raw material costs and competitive pricing. The net profit for the same period stood at ₹38 Cr, a significant improvement from the meager ₹3 Cr in the prior fiscal year, indicating a rebound in profitability. The interest coverage ratio of 3.99x also reflects a comfortable position to meet interest obligations, although it’s crucial to monitor the rising trend in debt, which grew to ₹832 Cr. The cash conversion cycle (CCC) of 63 days seems manageable, but the increase in inventory days to 87 could indicate inefficiencies in stock management, potentially impacting liquidity if not addressed promptly.
Balance Sheet Strength and Financial Ratios
Rane’s balance sheet shows a mixed picture of strength and vulnerability. Total borrowings have escalated to ₹832 Cr, which raises the debt-to-equity ratio to 1.15x, suggesting a relatively high leverage compared to the industry norm. This could be a concern, especially if interest rates rise further. However, the company’s reserves have increased significantly to ₹652 Cr, providing a buffer against financial strains. The return on equity (ROE) of 9.5% is modest but reflects an improving trend, particularly when juxtaposed against the tumultuous years of negative returns in the recent past. The price-to-book value ratio stands at 1.55x, indicating that the stock is trading at a premium over its book value, which could signal investor confidence but also implies expectations for future growth that need to be met. Overall, while the balance sheet shows resilience, the rising debt levels and associated risks warrant close scrutiny.
Shareholding Pattern and Investor Confidence
The shareholding pattern of Rane (Madras) Ltd reveals a predominantly promoter-driven structure, with promoters holding 70.45% of the equity as of June 2025. This strong promoter stake often signifies confidence in the company’s long-term prospects. However, the presence of foreign institutional investors (FIIs) remains negligible at 0.04%, which may indicate a lack of broader market appeal or concerns over the company’s volatility. On the other hand, domestic institutional investors (DIIs) have increased their stake to 1.04%, reflecting a cautious optimism among local investors. The number of shareholders surged to 32,127, suggesting growing retail interest, which is a positive sign for liquidity. Yet, the concentration of ownership among promoters could raise concerns about minority shareholder rights and decision-making transparency, making it crucial for the company to maintain open communication with all stakeholders.
Outlook, Risks, and Final Insight
Looking forward, Rane (Madras) Ltd operates in a sector that is poised for growth, but it is not without its challenges. The recovery in the automotive industry is a promising backdrop, yet the company must navigate increasing raw material costs and potential supply chain disruptions. Additionally, the rising debt levels could strain financial flexibility, especially if interest rates continue to climb. Investors should remain vigilant about the company’s ability to sustain its profitability amid these pressures. While the strong promoter backing and improving financial metrics instill some confidence, the volatility in quarterly results and the heavy reliance on domestic markets could pose risks. In summary, investors should weigh Rane’s growth potential against the backdrop of economic uncertainties and the inherent risks of the auto ancillary sector, making informed decisions based on both current performance and future market dynamics.
Source: Getaka Fundamental Analysis | Generated using proprietary financial data.
Competitors
| Stock Name ⇩ | Market Cap ⇩ | Current Price ⇩ | High / Low ⇩ | Stock P/E ⇩ | Book Value ⇩ | Dividend Yield ⇩ | ROCE ⇩ | ROE ⇩ | Face Value ⇩ |
|---|---|---|---|---|---|---|---|---|---|
| Rico Auto Industries Ltd | 1,604 Cr. | 119 | 126/49.5 | 36.6 | 55.7 | 0.42 % | 7.50 % | 3.48 % | 1.00 |
| Rane (Madras) Ltd | 2,048 Cr. | 741 | 1,055/575 | 42.6 | 246 | 1.08 % | 13.6 % | 9.50 % | 10.0 |
| Automotive Axles Ltd | 2,826 Cr. | 1,870 | 1,986/1,520 | 18.0 | 666 | 1.63 % | 22.3 % | 16.6 % | 10.0 |
| Industry Average | 2,159.33 Cr | 910.00 | 32.40 | 322.57 | 1.04% | 14.47% | 9.86% | 7.00 |
Quarterly Result
| Metric | Jun 2022 | Sep 2022 | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 549 | 600 | 583 | 622 | 588 | 611 | 521 | 853 | 818 | 529 | 837 | 901 | 881 |
| Expenses | 520 | 567 | 540 | 566 | 546 | 579 | 474 | 784 | 753 | 493 | 771 | 823 | 806 |
| Operating Profit | 29 | 33 | 43 | 55 | 42 | 32 | 47 | 69 | 65 | 36 | 66 | 79 | 75 |
| OPM % | 5% | 6% | 7% | 9% | 7% | 5% | 9% | 8% | 8% | 7% | 8% | 9% | 8% |
| Other Income | 1 | 0 | 27 | -1 | -17 | -85 | 1 | -4 | 6 | 2 | 2 | -8 | 3 |
| Interest | 5 | 7 | 9 | 13 | 14 | 13 | 15 | 16 | 17 | 16 | 20 | 18 | 17 |
| Depreciation | 22 | 22 | 25 | 28 | 24 | 24 | 21 | 33 | 32 | 21 | 33 | 36 | 36 |
| Profit before tax | 3 | 5 | 36 | 14 | -13 | -90 | 13 | 16 | 21 | 0 | 15 | 17 | 25 |
| Tax % | 198% | 99% | 34% | 31% | 7% | -120% | 29% | 31% | 32% | 274% | 97% | 62% | 25% |
| Net Profit | -3 | 0 | 24 | 10 | -14 | 18 | 9 | 11 | 15 | -1 | 0 | 7 | 19 |
| EPS in Rs | -2.02 | 0.03 | 14.58 | 5.87 | -8.90 | 10.93 | 5.59 | 6.62 | 8.99 | -0.42 | 0.24 | 4.01 | 6.70 |
Last Updated: August 20, 2025, 4:40 am
Below is a detailed analysis of the quarterly data for Rane (Madras) Ltd based on the most recent figures (Jun 2025) and their trends compared to the previous period:
- For Sales, as of Jun 2025, the value is 881.00 Cr.. The value appears to be declining and may need further review. It has decreased from 901.00 Cr. (Mar 2025) to 881.00 Cr., marking a decrease of 20.00 Cr..
- For Expenses, as of Jun 2025, the value is 806.00 Cr.. The value appears to be improving (decreasing) as expected. It has decreased from 823.00 Cr. (Mar 2025) to 806.00 Cr., marking a decrease of 17.00 Cr..
- For Operating Profit, as of Jun 2025, the value is 75.00 Cr.. The value appears to be declining and may need further review. It has decreased from 79.00 Cr. (Mar 2025) to 75.00 Cr., marking a decrease of 4.00 Cr..
- For OPM %, as of Jun 2025, the value is 8.00%. The value appears to be declining and may need further review. It has decreased from 9.00% (Mar 2025) to 8.00%, marking a decrease of 1.00%.
- For Other Income, as of Jun 2025, the value is 3.00 Cr.. The value appears strong and on an upward trend. It has increased from -8.00 Cr. (Mar 2025) to 3.00 Cr., marking an increase of 11.00 Cr..
- For Interest, as of Jun 2025, the value is 17.00 Cr.. The value appears to be improving (decreasing) as expected. It has decreased from 18.00 Cr. (Mar 2025) to 17.00 Cr., marking a decrease of 1.00 Cr..
- For Depreciation, as of Jun 2025, the value is 36.00 Cr.. The value remains steady. There is no change compared to the previous period (Mar 2025) which recorded 36.00 Cr..
- For Profit before tax, as of Jun 2025, the value is 25.00 Cr.. The value appears strong and on an upward trend. It has increased from 17.00 Cr. (Mar 2025) to 25.00 Cr., marking an increase of 8.00 Cr..
- For Tax %, as of Jun 2025, the value is 25.00%. The value appears to be improving (decreasing) as expected. It has decreased from 62.00% (Mar 2025) to 25.00%, marking a decrease of 37.00%.
- For Net Profit, as of Jun 2025, the value is 19.00 Cr.. The value appears strong and on an upward trend. It has increased from 7.00 Cr. (Mar 2025) to 19.00 Cr., marking an increase of 12.00 Cr..
- For EPS in Rs, as of Jun 2025, the value is 6.70. The value appears strong and on an upward trend. It has increased from 4.01 (Mar 2025) to 6.70, marking an increase of 2.69.
Overall, while many items appear to show a positive trend, any significant downward movement warrant further investigation.
Profit & Loss - Annual Report
Last Updated: October 15, 2025, 4:34 am
| Metric | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | TTM |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 876 | 1,195 | 1,400 | 1,555 | 1,277 | 1,267 | 1,742 | 2,354 | 2,239 | 3,406 | 3,148 |
| Expenses | 797 | 1,106 | 1,273 | 1,438 | 1,230 | 1,236 | 1,667 | 2,171 | 2,092 | 3,122 | 2,893 |
| Operating Profit | 79 | 89 | 127 | 117 | 47 | 31 | 75 | 184 | 147 | 284 | 255 |
| OPM % | 9% | 7% | 9% | 8% | 4% | 2% | 4% | 8% | 7% | 8% | 8% |
| Other Income | -2 | 11 | 9 | 10 | 12 | 7 | 52 | 6 | -101 | 2 | -1 |
| Interest | 19 | 30 | 34 | 35 | 38 | 28 | 21 | 35 | 57 | 76 | 71 |
| Depreciation | 41 | 57 | 61 | 66 | 66 | 66 | 81 | 97 | 91 | 132 | 125 |
| Profit before tax | 17 | 13 | 40 | 26 | -45 | -55 | 26 | 58 | -103 | 78 | 57 |
| Tax % | 27% | 66% | 40% | 91% | 2% | 10% | 58% | 49% | -103% | 52% | |
| Net Profit | 13 | 4 | 24 | 2 | -46 | -61 | 11 | 30 | 3 | 38 | 25 |
| EPS in Rs | 12.05 | 4.11 | 20.87 | 2.02 | -36.26 | -41.98 | 6.55 | 18.46 | 1.86 | 23.15 | 10.53 |
| Dividend Payout % | 37% | 146% | 58% | 420% | 0% | 0% | 0% | 0% | 0% | 35% |
YoY Net Profit Growth
| Year | 2016-2017 | 2017-2018 | 2018-2019 | 2019-2020 | 2020-2021 | 2021-2022 | 2022-2023 | 2023-2024 | 2024-2025 |
|---|---|---|---|---|---|---|---|---|---|
| YoY Net Profit Growth (%) | -69.23% | 500.00% | -91.67% | -2400.00% | -32.61% | 118.03% | 172.73% | -90.00% | 1166.67% |
| Change in YoY Net Profit Growth (%) | 0.00% | 569.23% | -591.67% | -2308.33% | 2367.39% | 150.64% | 54.69% | -262.73% | 1256.67% |
Rane (Madras) Ltd has shown an inconsistent trend in YoY Net Profit Growth (%) in the last 9 years from 2016-2017 to 2024-2025.
Growth
| Compounded Sales Growth | |
|---|---|
| 10 Years: | % |
| 5 Years: | 22% |
| 3 Years: | 25% |
| TTM: | 12% |
| Compounded Profit Growth | |
|---|---|
| 10 Years: | % |
| 5 Years: | 25% |
| 3 Years: | 60% |
| TTM: | -83% |
| Stock Price CAGR | |
|---|---|
| 10 Years: | 11% |
| 5 Years: | 31% |
| 3 Years: | 29% |
| 1 Year: | -37% |
| Return on Equity | |
|---|---|
| 10 Years: | % |
| 5 Years: | 8% |
| 3 Years: | 20% |
| Last Year: | 10% |
Last Updated: September 5, 2025, 1:00 pm
Balance Sheet
Last Updated: December 4, 2025, 1:52 am
| Month | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Sep 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Equity Capital | 11 | 11 | 12 | 12 | 13 | 15 | 16 | 16 | 16 | 16 | 28 |
| Reserves | 140 | 147 | 218 | 218 | 171 | 167 | 212 | 225 | 240 | 655 | 652 |
| Borrowings | 338 | 362 | 357 | 417 | 470 | 470 | 585 | 668 | 728 | 813 | 832 |
| Other Liabilities | 212 | 267 | 315 | 290 | 268 | 380 | 417 | 439 | 385 | 785 | 898 |
| Total Liabilities | 701 | 787 | 902 | 937 | 922 | 1,032 | 1,230 | 1,349 | 1,369 | 2,269 | 2,411 |
| Fixed Assets | 361 | 365 | 386 | 386 | 382 | 415 | 477 | 490 | 453 | 693 | 680 |
| CWIP | 7 | 28 | 16 | 16 | 50 | 31 | 18 | 29 | 27 | 73 | 97 |
| Investments | 0 | 0 | 0 | 1 | 1 | 1 | 1 | 1 | 2 | 7 | 7 |
| Other Assets | 333 | 394 | 499 | 535 | 489 | 586 | 733 | 829 | 887 | 1,496 | 1,626 |
| Total Assets | 701 | 787 | 902 | 937 | 922 | 1,032 | 1,230 | 1,349 | 1,369 | 2,269 | 2,411 |
Below is a detailed analysis of the balance sheet data for Rane (Madras) Ltd based on the most recent figures (Sep 2025) and their trends compared to the previous period:
- For Equity Capital, as of Sep 2025, the value is 28.00 Cr.. The value appears strong and on an upward trend. It has increased from 16.00 Cr. (Mar 2025) to 28.00 Cr., marking an increase of 12.00 Cr..
- For Reserves, as of Sep 2025, the value is 652.00 Cr.. The value appears to be declining and may need further review. It has decreased from 655.00 Cr. (Mar 2025) to 652.00 Cr., marking a decrease of 3.00 Cr..
- For Borrowings, as of Sep 2025, the value is 832.00 Cr.. The value appears to be increasing, which may not be favorable. However, Borrowings exceed Reserves, which may signal higher financial risk. It has increased from 813.00 Cr. (Mar 2025) to 832.00 Cr., marking an increase of 19.00 Cr..
- For Other Liabilities, as of Sep 2025, the value is 898.00 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 785.00 Cr. (Mar 2025) to 898.00 Cr., marking an increase of 113.00 Cr..
- For Total Liabilities, as of Sep 2025, the value is 2,411.00 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 2,269.00 Cr. (Mar 2025) to 2,411.00 Cr., marking an increase of 142.00 Cr..
- For Fixed Assets, as of Sep 2025, the value is 680.00 Cr.. The value appears to be declining and may need further review. It has decreased from 693.00 Cr. (Mar 2025) to 680.00 Cr., marking a decrease of 13.00 Cr..
- For CWIP, as of Sep 2025, the value is 97.00 Cr.. The value appears strong and on an upward trend. It has increased from 73.00 Cr. (Mar 2025) to 97.00 Cr., marking an increase of 24.00 Cr..
- For Investments, as of Sep 2025, the value is 7.00 Cr.. The value remains steady. There is no change compared to the previous period (Mar 2025) which recorded 7.00 Cr..
- For Other Assets, as of Sep 2025, the value is 1,626.00 Cr.. The value appears strong and on an upward trend. It has increased from 1,496.00 Cr. (Mar 2025) to 1,626.00 Cr., marking an increase of 130.00 Cr..
- For Total Assets, as of Sep 2025, the value is 2,411.00 Cr.. The value appears strong and on an upward trend. It has increased from 2,269.00 Cr. (Mar 2025) to 2,411.00 Cr., marking an increase of 142.00 Cr..
However, the Borrowings (832.00 Cr.) are higher than the Reserves (652.00 Cr.), which may signal higher financial risk.
Overall, while many items appear to show a positive trend, any significant downward movement or items where Borrowings exceed Reserves warrant further investigation.
Cash Flow - No data available for this post.
Free Cash Flow
| Month | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 |
|---|---|---|---|---|---|---|---|---|---|---|
| Free Cash Flow | -259.00 | -273.00 | -230.00 | -300.00 | -423.00 | -439.00 | -510.00 | -484.00 | -581.00 | -529.00 |
Free Cash Flow = Income Generated from Operational Activities - Borrowings - Capital Work in Progress (CWIP)
Consistent positive free cash flow is crucial for businesses as it indicates their ability to generate cash from their core operations. It provides financial flexibility, allowing companies to invest in growth opportunities, pay dividends to shareholders, reduce debt, and weather economic downturns more effectively.
Financial Efficiency Indicators
| Month | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 |
|---|---|---|---|---|---|---|---|---|---|---|
| Debtor Days | 67 | 57 | 64 | 58 | 55 | 78 | 74 | 65 | 55 | 76 |
| Inventory Days | 75 | 76 | 73 | 71 | 80 | 81 | 76 | 67 | 67 | 87 |
| Days Payable | 117 | 118 | 123 | 89 | 97 | 150 | 115 | 91 | 80 | 100 |
| Cash Conversion Cycle | 25 | 15 | 14 | 39 | 38 | 9 | 35 | 41 | 43 | 63 |
| Working Capital Days | -36 | -33 | -16 | -16 | -36 | -42 | -20 | -14 | -23 | -6 |
| ROCE % | 9% | 13% | 10% | -1% | -4% | -0% | 12% | 6% | 14% |
Mutual Fund Holdings
| Fund Name | No of Shares | AUM (%) | Amount Invested (Cr) | Previous Number of Shares | Previous Date | Percentage Change |
|---|---|---|---|---|---|---|
| Quant Business Cycle Fund | 101,795 | 1.06 | 8.46 | 101,795 | 2025-04-22 17:25:22 | 0% |
Key Financial Ratios
| Month | Mar 25 | Mar 24 | Mar 23 | Mar 22 | Mar 21 |
|---|---|---|---|---|---|
| FaceValue | 10.00 | 10.00 | 10.00 | 10.00 | 10.00 |
| Basic EPS (Rs.) | 13.62 | 1.85 | 18.46 | 6.97 | -47.66 |
| Diluted EPS (Rs.) | 13.62 | 1.85 | 18.46 | 6.97 | -47.66 |
| Cash EPS (Rs.) | 104.47 | 57.81 | 77.82 | 56.34 | 3.42 |
| Book Value[Excl.RevalReserv]/Share (Rs.) | 405.36 | 157.32 | 148.52 | 140.22 | 124.84 |
| Book Value[Incl.RevalReserv]/Share (Rs.) | 405.36 | 157.32 | 148.52 | 140.22 | 124.84 |
| Revenue From Operations / Share (Rs.) | 2093.27 | 1376.12 | 1447.11 | 1070.63 | 869.86 |
| PBDIT / Share (Rs.) | 183.01 | 92.62 | 123.15 | 48.84 | 25.87 |
| PBIT / Share (Rs.) | 101.68 | 36.67 | 63.77 | -0.94 | -19.51 |
| PBT / Share (Rs.) | 47.88 | -63.01 | 35.93 | 15.69 | -38.07 |
| Net Profit / Share (Rs.) | 23.14 | 1.86 | 18.45 | 6.55 | -41.96 |
| NP After MI And SOA / Share (Rs.) | 23.14 | 1.86 | 18.45 | 6.55 | -41.96 |
| PBDIT Margin (%) | 8.74 | 6.73 | 8.50 | 4.56 | 2.97 |
| PBIT Margin (%) | 4.85 | 2.66 | 4.40 | -0.08 | -2.24 |
| PBT Margin (%) | 2.28 | -4.57 | 2.48 | 1.46 | -4.37 |
| Net Profit Margin (%) | 1.10 | 0.13 | 1.27 | 0.61 | -4.82 |
| NP After MI And SOA Margin (%) | 1.10 | 0.13 | 1.27 | 0.61 | -4.82 |
| Return on Networth / Equity (%) | 5.70 | 1.17 | 12.42 | 4.67 | -33.61 |
| Return on Capital Employeed (%) | 17.23 | 10.77 | 19.82 | -0.30 | -6.90 |
| Return On Assets (%) | 1.65 | 0.22 | 2.22 | 0.86 | -5.92 |
| Long Term Debt / Equity (X) | 0.32 | 1.02 | 1.01 | 1.03 | 1.04 |
| Total Debt / Equity (X) | 1.15 | 2.74 | 2.72 | 2.52 | 1.99 |
| Asset Turnover Ratio (%) | 1.87 | 1.65 | 1.83 | 1.40 | 1.23 |
| Current Ratio (X) | 0.98 | 0.85 | 0.92 | 0.88 | 0.77 |
| Quick Ratio (X) | 0.65 | 0.56 | 0.61 | 0.59 | 0.52 |
| Inventory Turnover Ratio (X) | 10.10 | 5.74 | 6.44 | 6.00 | 5.04 |
| Dividend Payout Ratio (NP) (%) | 71.20 | 0.00 | 0.00 | 0.00 | 0.00 |
| Dividend Payout Ratio (CP) (%) | 15.77 | 0.00 | 0.00 | 0.00 | 0.00 |
| Earning Retention Ratio (%) | 28.80 | 0.00 | 0.00 | 0.00 | 0.00 |
| Cash Earning Retention Ratio (%) | 84.23 | 0.00 | 0.00 | 0.00 | 0.00 |
| Interest Coverage Ratio (X) | 3.99 | 2.67 | 5.96 | 4.05 | 1.39 |
| Interest Coverage Ratio (Post Tax) (X) | 1.68 | 2.93 | 2.24 | -0.83 | -1.26 |
| Enterprise Value (Cr.) | 1750.42 | 1796.95 | 1291.49 | 1135.96 | 898.14 |
| EV / Net Operating Revenue (X) | 0.51 | 0.80 | 0.54 | 0.65 | 0.70 |
| EV / EBITDA (X) | 5.88 | 11.92 | 6.45 | 14.29 | 23.83 |
| MarketCap / Net Operating Revenue (X) | 0.30 | 0.50 | 0.28 | 0.32 | 0.42 |
| Retention Ratios (%) | 28.79 | 0.00 | 0.00 | 0.00 | 0.00 |
| Price / BV (X) | 1.55 | 4.38 | 2.74 | 2.51 | 2.99 |
| Price / Net Operating Revenue (X) | 0.30 | 0.50 | 0.28 | 0.32 | 0.42 |
| EarningsYield | 0.03 | 0.00 | 0.04 | 0.01 | -0.11 |
After reviewing the key financial ratios for Rane (Madras) Ltd, here is a detailed analysis based on the latest available data and recent trends:
- For FaceValue, as of Mar 25, the value is 10.00. This value is within the healthy range. There is no change compared to the previous period (Mar 24) which recorded 10.00.
- For Basic EPS (Rs.), as of Mar 25, the value is 13.62. This value is within the healthy range. It has increased from 1.85 (Mar 24) to 13.62, marking an increase of 11.77.
- For Diluted EPS (Rs.), as of Mar 25, the value is 13.62. This value is within the healthy range. It has increased from 1.85 (Mar 24) to 13.62, marking an increase of 11.77.
- For Cash EPS (Rs.), as of Mar 25, the value is 104.47. This value is within the healthy range. It has increased from 57.81 (Mar 24) to 104.47, marking an increase of 46.66.
- For Book Value[Excl.RevalReserv]/Share (Rs.), as of Mar 25, the value is 405.36. It has increased from 157.32 (Mar 24) to 405.36, marking an increase of 248.04.
- For Book Value[Incl.RevalReserv]/Share (Rs.), as of Mar 25, the value is 405.36. It has increased from 157.32 (Mar 24) to 405.36, marking an increase of 248.04.
- For Revenue From Operations / Share (Rs.), as of Mar 25, the value is 2,093.27. It has increased from 1,376.12 (Mar 24) to 2,093.27, marking an increase of 717.15.
- For PBDIT / Share (Rs.), as of Mar 25, the value is 183.01. This value is within the healthy range. It has increased from 92.62 (Mar 24) to 183.01, marking an increase of 90.39.
- For PBIT / Share (Rs.), as of Mar 25, the value is 101.68. This value is within the healthy range. It has increased from 36.67 (Mar 24) to 101.68, marking an increase of 65.01.
- For PBT / Share (Rs.), as of Mar 25, the value is 47.88. This value is within the healthy range. It has increased from -63.01 (Mar 24) to 47.88, marking an increase of 110.89.
- For Net Profit / Share (Rs.), as of Mar 25, the value is 23.14. This value is within the healthy range. It has increased from 1.86 (Mar 24) to 23.14, marking an increase of 21.28.
- For NP After MI And SOA / Share (Rs.), as of Mar 25, the value is 23.14. This value is within the healthy range. It has increased from 1.86 (Mar 24) to 23.14, marking an increase of 21.28.
- For PBDIT Margin (%), as of Mar 25, the value is 8.74. This value is below the healthy minimum of 10. It has increased from 6.73 (Mar 24) to 8.74, marking an increase of 2.01.
- For PBIT Margin (%), as of Mar 25, the value is 4.85. This value is below the healthy minimum of 10. It has increased from 2.66 (Mar 24) to 4.85, marking an increase of 2.19.
- For PBT Margin (%), as of Mar 25, the value is 2.28. This value is below the healthy minimum of 10. It has increased from -4.57 (Mar 24) to 2.28, marking an increase of 6.85.
- For Net Profit Margin (%), as of Mar 25, the value is 1.10. This value is below the healthy minimum of 5. It has increased from 0.13 (Mar 24) to 1.10, marking an increase of 0.97.
- For NP After MI And SOA Margin (%), as of Mar 25, the value is 1.10. This value is below the healthy minimum of 8. It has increased from 0.13 (Mar 24) to 1.10, marking an increase of 0.97.
- For Return on Networth / Equity (%), as of Mar 25, the value is 5.70. This value is below the healthy minimum of 15. It has increased from 1.17 (Mar 24) to 5.70, marking an increase of 4.53.
- For Return on Capital Employeed (%), as of Mar 25, the value is 17.23. This value is within the healthy range. It has increased from 10.77 (Mar 24) to 17.23, marking an increase of 6.46.
- For Return On Assets (%), as of Mar 25, the value is 1.65. This value is below the healthy minimum of 5. It has increased from 0.22 (Mar 24) to 1.65, marking an increase of 1.43.
- For Long Term Debt / Equity (X), as of Mar 25, the value is 0.32. This value is within the healthy range. It has decreased from 1.02 (Mar 24) to 0.32, marking a decrease of 0.70.
- For Total Debt / Equity (X), as of Mar 25, the value is 1.15. This value exceeds the healthy maximum of 1. It has decreased from 2.74 (Mar 24) to 1.15, marking a decrease of 1.59.
- For Asset Turnover Ratio (%), as of Mar 25, the value is 1.87. It has increased from 1.65 (Mar 24) to 1.87, marking an increase of 0.22.
- For Current Ratio (X), as of Mar 25, the value is 0.98. This value is below the healthy minimum of 1.5. It has increased from 0.85 (Mar 24) to 0.98, marking an increase of 0.13.
- For Quick Ratio (X), as of Mar 25, the value is 0.65. This value is below the healthy minimum of 1. It has increased from 0.56 (Mar 24) to 0.65, marking an increase of 0.09.
- For Inventory Turnover Ratio (X), as of Mar 25, the value is 10.10. This value exceeds the healthy maximum of 8. It has increased from 5.74 (Mar 24) to 10.10, marking an increase of 4.36.
- For Dividend Payout Ratio (NP) (%), as of Mar 25, the value is 71.20. This value exceeds the healthy maximum of 50. It has increased from 0.00 (Mar 24) to 71.20, marking an increase of 71.20.
- For Dividend Payout Ratio (CP) (%), as of Mar 25, the value is 15.77. This value is below the healthy minimum of 20. It has increased from 0.00 (Mar 24) to 15.77, marking an increase of 15.77.
- For Earning Retention Ratio (%), as of Mar 25, the value is 28.80. This value is below the healthy minimum of 40. It has increased from 0.00 (Mar 24) to 28.80, marking an increase of 28.80.
- For Cash Earning Retention Ratio (%), as of Mar 25, the value is 84.23. This value exceeds the healthy maximum of 70. It has increased from 0.00 (Mar 24) to 84.23, marking an increase of 84.23.
- For Interest Coverage Ratio (X), as of Mar 25, the value is 3.99. This value is within the healthy range. It has increased from 2.67 (Mar 24) to 3.99, marking an increase of 1.32.
- For Interest Coverage Ratio (Post Tax) (X), as of Mar 25, the value is 1.68. This value is below the healthy minimum of 3. It has decreased from 2.93 (Mar 24) to 1.68, marking a decrease of 1.25.
- For Enterprise Value (Cr.), as of Mar 25, the value is 1,750.42. It has decreased from 1,796.95 (Mar 24) to 1,750.42, marking a decrease of 46.53.
- For EV / Net Operating Revenue (X), as of Mar 25, the value is 0.51. This value is below the healthy minimum of 1. It has decreased from 0.80 (Mar 24) to 0.51, marking a decrease of 0.29.
- For EV / EBITDA (X), as of Mar 25, the value is 5.88. This value is within the healthy range. It has decreased from 11.92 (Mar 24) to 5.88, marking a decrease of 6.04.
- For MarketCap / Net Operating Revenue (X), as of Mar 25, the value is 0.30. This value is below the healthy minimum of 1. It has decreased from 0.50 (Mar 24) to 0.30, marking a decrease of 0.20.
- For Retention Ratios (%), as of Mar 25, the value is 28.79. This value is below the healthy minimum of 30. It has increased from 0.00 (Mar 24) to 28.79, marking an increase of 28.79.
- For Price / BV (X), as of Mar 25, the value is 1.55. This value is within the healthy range. It has decreased from 4.38 (Mar 24) to 1.55, marking a decrease of 2.83.
- For Price / Net Operating Revenue (X), as of Mar 25, the value is 0.30. This value is below the healthy minimum of 1. It has decreased from 0.50 (Mar 24) to 0.30, marking a decrease of 0.20.
- For EarningsYield, as of Mar 25, the value is 0.03. This value is below the healthy minimum of 5. It has increased from 0.00 (Mar 24) to 0.03, marking an increase of 0.03.
Overall, while many metrics show healthy performance, any figures highlighted in red or significant downward trends warrant further investigation.
Strength and Weakness
| Strength | Weakness |
|---|---|
|
|
Stock Analysis
- Considering all of the following key financial indicators, prospective investors are encouraged to conduct thorough research and seek professional guidance before considering any investment in Rane (Madras) Ltd:
- Net Profit Margin: 1.1%
- Net Profit Margin: This metric indicates the percentage of profit a company makes from its total revenue. A higher net profit margin is generally desirable as it reflects better profitability.
- ROCE: 17.23% (Industry Average ROCE: 14.47%)
- ROCE (Return on Capital Employed): ROCE measures a company's profitability and the efficiency with which its capital is employed. A higher ROCE indicates efficient use of capital.
- ROE%: 5.7% (Industry Average ROE: 9.86%)
- ROE (Return on Equity): ROE measures a company's profitability relative to shareholders' equity. A higher ROE indicates efficient use of shareholders' funds.
- Interest Coverage Ratio (Post Tax): 1.68
- Interest Coverage Ratio: The interest coverage ratio measures a company's ability to cover its interest payments on outstanding debt. A ratio greater than 2 is generally considered healthy as it indicates the company can meet its interest obligations comfortably.
- Quick Ratio: 0.65
- Quick Ratio: The quick ratio assesses a company's ability to cover its short-term liabilities with its most liquid assets. A ratio higher than 1 suggests the company can meet its short-term obligations without relying heavily on inventory.
- Stock P/E: 42.6 (Industry average Stock P/E: 32.4)
- Stock P/E (Price-to-Earnings) Ratio: The P/E ratio compares a company's current share price to its earnings per share. A lower P/E ratio relative to industry peers or historical values may indicate that the stock is undervalued.
- Total Debt / Equity: 1.15
- Total Debt / Equity: This ratio measures a company's financial leverage by comparing its total debt to its total equity. A lower ratio indicates lower financial risk and greater financial stability.
Stock Rating: - Net Profit Margin: 1.1%
About the Company - Qualitative Analysis
| INDUSTRY | ADDRESS | CONTACT |
|---|---|---|
| Auto Ancl - Dr. Trans & Steer - Others | MAITHRI, Chennai (Madras) Tamil Nadu 600086 | investorservices@ranegroup.com http://www.ranegroup.com |
| Management | |
|---|---|
| Name | Position Held |
| Mr. Harish Lakshman | Chairman & Managing Director |
| Ms. Vasudha Sundararaman | Director |
| Mr. Pradip Kumar Bishnoi | Director |
| Mr. L Ganesh | Director |
| Mr. N Ramesh Rajan | Director |
| Mr. Vikram Hosangady | Director |
FAQ
What is the intrinsic value of Rane (Madras) Ltd?
Rane (Madras) Ltd's intrinsic value (as of 13 December 2025) is 805.05 which is 8.64% higher the current market price of 741.00, indicating undervalued. Calculated using the PE ratio method, this valuation considers the company's 2,048 Cr. market cap, FY2025-2026 high/low of 1,055/575, reserves of ₹652 Cr, and liabilities of 2,411 Cr.
What is the Market Cap of Rane (Madras) Ltd?
The Market Cap of Rane (Madras) Ltd is 2,048 Cr..
What is the current Stock Price of Rane (Madras) Ltd as on 13 December 2025?
The current stock price of Rane (Madras) Ltd as on 13 December 2025 is 741.
What is the High / Low of Rane (Madras) Ltd stocks in FY 2025-2026?
In FY 2025-2026, the High / Low of Rane (Madras) Ltd stocks is 1,055/575.
What is the Stock P/E of Rane (Madras) Ltd?
The Stock P/E of Rane (Madras) Ltd is 42.6.
What is the Book Value of Rane (Madras) Ltd?
The Book Value of Rane (Madras) Ltd is 246.
What is the Dividend Yield of Rane (Madras) Ltd?
The Dividend Yield of Rane (Madras) Ltd is 1.08 %.
What is the ROCE of Rane (Madras) Ltd?
The ROCE of Rane (Madras) Ltd is 13.6 %.
What is the ROE of Rane (Madras) Ltd?
The ROE of Rane (Madras) Ltd is 9.50 %.
What is the Face Value of Rane (Madras) Ltd?
The Face Value of Rane (Madras) Ltd is 10.0.